Use of Aspirin to Reduce Risks of Cardiovascular Disease in Patients With Diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of Aspirin to Reduce Risks of Cardiovascular Disease in Patients With Diabetes

Published:2004-11-01 Issue:11 Volume:27 Page:2752-2754
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Hennekens Charles H.¹²³,Knatterud Genell L.⁴,Pfeffer Marc A.⁵

Affiliation:

1. Departments of Medicine & Epidemiology and Public Health, University of Miami School of Medicine, Miami, Florida

2. Agatston Research Institute, Miami Beach, Florida

3. Department of Biomedical Science, Center of Excellence, Florida Atlantic University, Boca Raton, Florida

4. Maryland Medical Research Institute, Baltimore, Maryland

5. Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massaschusetts

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/27/11/2752/562416/zdc01104002752.pdf

Reference22 articles.

1. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel or ATP III): Executive summary of the third report of the National Cholesterol Program (NCEP III). JAMA 285:2486–2497, 2001

2. Eidelman RS, Lamas GA, Hennekens CH: The new National Cholesterol Education Program guidelines: clinical challenges for more widespread therapy of lipids to treat and prevent coronary hear disease. Arch Intern Med 162:2033–2038, 2002

3. Hennekens CH: Increasing global burden of cardiovascular disease: current knowledge and future directions for research on risk factors: special report: the 1997 American Heart Association’s Lewis Atterbury Conner Lecture. Circulation 97:1095–1102, 1998

4. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krowlewski As, Rosner B, Arky RA, Speizer FE, Hennekens CH: A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 151:1141–1147, 1991

5. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234, 1998

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-steroidal anti-inflammatory drugs and risk of Parkinson’s disease in the elderly population: a meta-analysis;European Journal of Clinical Pharmacology;2018-10-02

2. Aspirin for Primary Prevention in Patients with Type 2 Diabetes;Endocrine Practice;2018-10

3. Telemedicine cardiovascular risk reduction in Veterans;American Heart Journal;2013-04

4. ¿Antiagregamos adecuadamente a los pacientes diabéticos tipo 2?;SEMERGEN - Medicina de Familia;2012-09

5. Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus;Diabetes Research and Clinical Practice;2011-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3